Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU25F0J83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,030
Award facts
- Contract value 100% obligated
- $2,030.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,030.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on September 17, 2025, represents a firm fixed-price purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The contract required no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare facilities.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion DLA acquisition strategy designed to ensure reliable pharmaceutical supply for Department of Defense healthcare operations globally. The contractor's established performance on numerous prior delivery orders and its extensive product portfolio spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals position DMS Pharmaceutical Group as a key regional prime vendor supporting the military medical system's diverse pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DU25F0J83?
SPE2DU25F0J83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DU25F0J83 worth?
The government has obligated $2,030 on SPE2DU25F0J83.
Is contract SPE2DU25F0J83 an order under another contract?
Yes. SPE2DU25F0J83 is a delivery order under SPE2DU25D9811, an indefinite delivery contract.
Was contract SPE2DU25F0J83 competed?
The extent of competition for SPE2DU25F0J83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award